USP8 and hepatocellular carcinoma: As shown in Fig. 6, inhibition of USP8 by DUB-IN-3 caused a dose-dependent suppression on the proliferation, invasion, stem-like properties and promoted ferroptosis of HCC cells (Fig. 6A–J).